Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of Lybridos buspirone pharmacokinetics in healthy women
NL-OMON22366Active, not recruiting
- Sponsor
- EB FlevoResearch
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lybridos and buspirone in female sexual dysfunction (FSD) (2 arms), sponsored by EB FlevoResearch. Primary endpoints: AUC0-inf ratio (fed vs fasted) and Cmax ratio (fed vs fasted). Started Mar 2015; status: active, not recruiting.
02
Drugs
Lybridosbuspirone
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON22366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22366.